August 2016: United States
Letter
Submission to court in the challenge to FDA deeming rule
A brief of amici curiae in the case of Nicopure et al vs FDA – the brief argues that FDA’s cost-benefit analysis has no material benefits and ignores huge health costs and unintended consequences. With 15 experts.